Understanding and treating neurodevelopmental disorders in children
Clinical Translational Research Center for Neurodevelopmental Disorders
This study is looking into what causes and how to treat autism and similar conditions in kids aged 0-11, and it aims to help families by finding better ways to spot and support these challenges early on.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10906773 on NIH RePORTER |
What this research studies
This research focuses on understanding the causes and treatments for neurodevelopmental disorders, particularly autism and related conditions, in children aged 0-11 years. The program is based at the University of North Carolina and involves a collaborative effort among various departments to promote innovative research and clinical services. Patients may benefit from early detection and intervention strategies developed through this research, which includes both clinical and preclinical studies. The research utilizes advanced methodologies, including participant registries and behavioral assessments, to gather data and improve treatment approaches.
Who could benefit from this research
Good fit: Ideal candidates for participation are children aged 0-11 years who are diagnosed with autism spectrum disorder or other neurodevelopmental disorders.
Not a fit: Patients who are older than 11 years or do not have a neurodevelopmental disorder may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and treatment options for children with neurodevelopmental disorders.
How similar studies have performed: Previous research in similar areas has shown promise in developing effective interventions for neurodevelopmental disorders, indicating that this approach has the potential for success.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Dichter, Gabriel S — Univ of North Carolina Chapel Hill
- Study coordinator: Dichter, Gabriel S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.